164
Participants
Start Date
October 31, 2025
Primary Completion Date
November 30, 2027
Study Completion Date
August 31, 2028
Zelquistinel
Zelquistinel is a positive allosteric modulator of the N-Methyl-D-Aspartate (NMDA) receptor
University of Alabama at Birmingham, Birmingham
Collaborators (1)
Worldwide Clinical Trials
OTHER
Syndeio Biosciences, Inc
INDUSTRY